Advancements in Targeted Therapies for Hematologic and Oncologic Disorders
DOI:
https://doi.org/10.56570/jimgs.v2i2.139Keywords:
Targeted therapies, Precision medicine, Genetic makeup, Hematology and oncology, Therapeutic outcomesAbstract
In recent years, significant advancements in medical science have led to the emergence of targeted therapies as a promising approach in treating hematologic and oncologic disorders. Precision medicine has revolutionized the landscape of healthcare, enabling physicians to tailor treatment plans based on an individuals genetic makeup. thus optimizing therapeutic outcomes. This poster explores how physicians can contribute to implementing precision medicine approaches in treating blood disorders and cancer
References
Targeted Therapies in Hematology and Their Impact on Patient Care: Chronic and Acute Myeloid Leukemia Authors: Elias Jabbour, Jorge Cortes, Farhad Ravandi Susan O'Brien PubMed Central ID (PMCID): PMC4098770 NIH Manuscript Submission ID (NIHMSID): NIHMS593287 PubMed ID (PMID): 24246694
Major Advances in the Treatment of Cancer: What does a Non-Oncologist need to know? Authors: Ikram A Burney and Mansour $ Al-Moundhri PubMed Central ID [PMCID: PMC3074830 PubMed ID (PMID): 21748051
Emerging Therapeutic Agents for Advanced Non-Small Cell Lung Cancer Authors: Chen, R., Manochakian, R., James, L., et al. Journal: Journal of Hematology Oncology Year: 2020 Volume: 13 Page: 58
